Patients treated with a tumor necrosis factor-alpha inhibitor are more likely to develop extrapulmonary tuberculosis.
10.3904/kjim.2013.28.2.159
- Author:
Sang Oh LEE
1
Author Information
1. Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Korea. soleemd@amc.seoul.kr
- Publication Type:Comment ; Editorial
- MeSH:
Female;
Humans;
*Immunocompromised Host;
Immunosuppressive Agents/*adverse effects;
Male;
Tuberculosis/*immunology;
Tumor Necrosis Factor-alpha/*antagonists & inhibitors
- From:The Korean Journal of Internal Medicine
2013;28(2):159-161
- CountryRepublic of Korea
- Language:English
-
Abstract:
No abstract available.
